Analysts' Actions: AMD, BAM, BX, GEN
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Advanced Micro Devices (AMD) was downgraded at Sterne Agee to Neutral from Buy. $8.50 price target. Slowing PC market limits upside, Sterne Agee said.
Brookfield Asset Management (BAM) was downgraded at Credit Suisse to Neutral from Outperform. $38 price target. Limited excess potential return, Credit Suisse said.
The Blackstone Group (BX) was upgraded at BMO to Outperform from Market Perform. $17 price target. Strong new asset growth, BMO said.
Nippon Telegraph and Telephone Corp. (NTT) was upgraded to Buy at TheStreet Ratings. Patrick Industries Inc. (PATK) was upgraded to Buy at TheStreet Ratings. Seattle Genetics (SGEN) was initiated with a Buy rating at Think Equity. $30 price target. Adcetris opportunity in Hodgkin's lymphoma, Think Equity said.STOCK COMMENTS / EPS CHANGES
Boeing (BA) estimates were raised at UBS through 2012. Strong delivery mix, UBS said. Neutral rating and $72 price target. CME Group (CME) estimates were raised at Jefferies through 2013. Volume trends improved throughout quarter, Jefferies said. Buy rating. EMC (EMC) numbers were lowered at Oppenheimer. Shares are now seen reaching $32. Estimates were also lowered on channel checks in the financial vertical, Oppenheimer said. Outperform rating. Lennar (LEN) target was raised at Deutsche Bank. Shares are now seen reaching $30. Taking advantage of rising demand, Deutsche Bank said. Hold rating. SXC Health Solutions Corp. (SXCI) numbers were raised at Credit Suisse. Shares are now seen reaching $111. Estimates were also raised on focus on fiscal 2013 and 2014, Credit Suisse said. Outperform rating. >To submit a news tip, email: tips@thestreet.com.Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
